Edwards Lifesciences Corporation (EW): $15.22 million was the positive money flow into the stock on Friday and the up/down ratio of ticks was also in favor of the bulls at 1.68. The value of trades done on upticks was $37.53 million, whereas, trades done on downticks were valued at $22.32 million. Money flows are calculated as the dollar value of composite uptick trades minus the dollar value of downtick trades. large traders, also sometimes called as the smart money, block traded $13.12 million worth stocks on upticks, which is a bullish indication. The downticks accounted only for $1.46 million worth of block trades showing a lack of interest among the large traders to sell the stock down. The up/down ratio of 9.01 was strongly in favor of the bulls. The money flow in block trades was $11.66 million. Edwards Lifesciences Corporation (EW) fell $0.02 traded at $115.85, a change of -0.02% over the previous day. The stock is 0.51% for the week.
The company Insiders own 2.37% of Edwards Lifesciences Corporation shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -6.48% . Institutional Investors own 85.59% of Edwards Lifesciences Corporation shares. During last six month period, the net percent change held by insiders has seen a change of -6.48%.
In a related news, The Securities and Exchange Commission has divulged that Verguet Patrick B, officer (CVP, Europe) of Edwards Lifesciences Corp, had unloaded 5,000 shares at an average price of $114.88 in a transaction dated on August 26, 2016. The total value of the transaction was worth $574,400.
Edwards Lifesciences Corporation (NYSE:EW): stock was range-bound between the intraday low of $115.23 and the intraday high of $116.28 after having opened at $115.87 on Fridays session. The stock finally closed in the red at $115.87, a loss of -0.02%. The stock remained in the red for the whole trading day. The total traded volume was 931,557 shares. The stock failed to cross $116.28 in Fridays trading. The stocks closing price on Thursday was $115.87.
Edwards Lifesciences Corporation (EW) : Traders are bullish on Edwards Lifesciences Corporation (EW) as it has outperformed the S&P 500 by a wide margin of 2.45% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.01%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.51% in the last 1 week, and is up 2.31% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. It is a manufacturer of heart valve systems and repair products used to replace or repair a patients diseased or defective heart valve. The Company develops hemodynamic monitoring systems used to measure a patients cardiovascular function in the hospital setting. Patients in the hospital setting, including high-risk patients in the operating room or intensive care unit, are candidates for having their cardiac function or fluid levels monitored by the its Critical Care products. The Companys products and technologies it offers to treat advanced cardiovascular disease are categorized into three main areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care.